Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Efficacy and Safety of First‐Line Treatment Options for Oncogene Wild‐Type Lung Adenocarcinoma With Liver Metastases

Liver metastasis represents one of the frequent drivers for cancer‐related mortality in lung adenocarcinoma. For advanced lung adenocarcinoma harboring wild‐type oncogene drivers, chemotherapies in combination with immune checkpoint inhibitors (ICIs) and/or bevacizumab (named IC, BC, and IBC, respectively) are alternat...

Jie Li, Yi-Hui Ge, Qiao-Hong Liu et al. · 0 citations
Review Open access Oct 2026

18F-FDG PET/CT radiomics across treatment timepoints for predicting response to neoadjuvant therapy in locally advanced esophageal cancer: a systematic review and meta-analysis

Pathological complete response (pCR) after neoadjuvant therapy is achieved in only about 20%–40% of patients with locally advanced esophageal cancer (LAEC), yet it is the strongest determinant of long-term survival. 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT)...

Jie Li, S. Suppiah, Lingeswaran Kasilingam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.